AVCNF.US Avicanna Inc

Healthcare Pharmaceuticals USA Stocks
0.0690 USD
Close of Nov 14, 2026
0.0560 0.1910
Market cap
USD 9.27M
P/E
-
P/B
2.65x
ROE
-69.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is AVCNF.US undervalued?

Graham number

The Graham number of Avicanna Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Avicanna Inc fundamental analysis

No fundamental analysis for Avicanna Inc yet.

Avicanna Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Avicanna Inc

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific cannabinoid-b…

Full company profile